RSS feeds from ecb.co.uk

Investec Tests news RSS

ECB clarifies Flintoff treatment

Investec Test Series

Andrew Flintoff

A decision on Andrew Flintoff's potential participation in the final Ashes Test at the Brit Oval will be made in due course

Following Andrew Flintoff’s omission from the England team for the fourth npower Test at Headingley Carnegie, the ECB medical team today released more information concerning the treatment of his injury.

In order to give Flintoff a chance of playing in the second and third Test matches, he received a series of artificial synovial fluid injections into the knee joint and cortisone injections into some of the bursa on the outside of the knee joint to help settle the inflammation.

There have been some media reports of repeated cortisone injections into the knee to mask the injury, but these reports are inaccurate.

Flintoff has shown great determination and selflessness making a conscious decision to push through discomfort in order to help the England team reclaim the Ashes. This is in the knowledge that a further operation is a possibility.

Flintoff is still very keen to play in the fifth Test at the Brit Oval and a decision on this will be made in due course.

He will not be exposed to undue risk or masking injections and any decision regarding his participation in the fifth Test will be made in conjunction with the ECB, his surgeon and the Lancashire medical team.